申请人:Aube Jeffrey
公开号:US20140371227A1
公开(公告)日:2014-12-18
The present invention is a selective kappa opioid receptor effector, or a pharmaceutically acceptable salt thereof, useful for treating ethanol use disorder withdrawal, anxiety and/or depression, schizophrenia, mania or post-traumatic stress disorder.
本发明是一种选择性kappa阿片受体效应物,或其药学上可接受的盐,用于治疗酒精使用障碍的戒断、焦虑和/或抑郁、精神分裂症、躁狂或创伤后应激障碍。